IPP Bureau
Lonza and Stipple Bio partner to advance next-generation precision oncology ADC therapies
By IPP Bureau - June 05, 2026
Multi-target licensing agreement combines Stipple Bio’s epitope discovery platform with Lonza’s ADC technologies to develop targeted cancer treatments
Aurobindo Pharma receives USFDA nod for generic Tofacitinib tablets
By IPP Bureau - June 05, 2026
Approval for generic version of Xeljanz enables immediate launch and strengthens Aurobindo’s U.S. portfolio with its 586th ANDA approval
Suven Life reports positive interim review for phase 3 Alzheimer’s therapy
By IPP Bureau - June 05, 2026
Independent DSMB recommends continuation of Masupirdine without modifications as enrollment reaches 88% in global trial
Kaushik Deb elevated to Vice President at Mankind Pharma
By IPP Bureau - June 05, 2026
Seasoned pharma leader recognized for driving sales excellence, marketing strategy, and business growth
CBC India partners with Metalco-Alupack to strengthen pharma aluminium packaging solutions
By IPP Bureau - June 05, 2026
Exclusive partnership to expand access to high-quality seamless anodized aluminium packaging for sterile APIs and pharmaceutical products across India.
Glenmark launches generic Lacosamide Injection USP in US Market
By IPP Bureau - June 05, 2026
Company expands injectable portfolio with therapeutically equivalent version of Vimpat®, targeting a market valued at approximately $15.2 million annually
Rahul Pasumarthy joins Apollo Hospitals as Vice President – Apollo International
By IPP Bureau - June 05, 2026
Healthcare industry leader returns to India to support Apollo Hospitals’ global expansion and advance the ‘Heal in India, Heal by India’ vision
Aurobindo Pharma launches TheraNym, India’s largest biologics CMO
By IPP Bureau - June 05, 2026
MSD joins as anchor customer as Aurobindo strengthens its position in the fast-growing global biologics manufacturing market
CORONA Remedies spearheads green footprint campaign on World Environment Day
By IPP Bureau - June 05, 2026
The company recycled approximately 100 kilograms of textile waste, undertook plantation activities, and encouraged employees to adopt environmentally responsible practices
Finerenone expands promise beyond diabetic kidney disease
By IPP Bureau - June 05, 2026
The drug currently approved for chronic kidney disease (CKD) associated with type 2 diabetes, may benefit a much broader group of patients than previously recognized
Wanbury FY26 PAT surges 117% to Rs. 66.1 crore
By IPP Bureau - June 05, 2026
SS Innovations sets world record with longest-distance robotic cardiac telesurgery
By IPP Bureau - June 05, 2026
The robotic cardiac procedure between Guyana and India, established a new benchmark in global telesurgery across nearly 20,000 kilometres
Teva expands European biosimilars push with AHZANTIVE launch for eye disease treatment
By IPP Bureau - June 05, 2026
Teva said the launch strengthens its biosimilars strategy and expands access to biologic medicines across Europe
Omnix Medical advances first-in-class antimicrobial OMN6 into Phase II trials
By IPP Bureau - June 05, 2026
Targeting deadly drug-resistant acinetobacter infections
Muthukumar Anbalagan joins Intas Pharma as General Manager – NDDS
By IPP Bureau - June 05, 2026
Anbalagan has led end-to-end product development programs from concept to commercialization, with a strong focus on regulatory compliance, process scalability, and manufacturing readiness
